Contents
In the modern era, every advancement in healthcare comes from studies. Clinical research in Nevada has a history of finding the best medical treatments, devices, drugs, and diets.
Nevada is a smaller research state, and it helps to know that going in. As of July 2026, 547 studies are actively recruiting volunteers here, according to ClinicalTrials.gov — far fewer than in California or Arizona next door. The activity that does exist concentrates in Las Vegas and Reno, and remote or decentralized studies give Nevadans access to trials run from anywhere.
Quick Facts: Paid Clinical Trials in Nevada
- Actively recruiting studies (July 2026): 547 (ClinicalTrials.gov)
- Typical compensation: $50–$100 per completed outpatient visit; residential Phase 1 studies pay more (see highest paid clinical trials)
- Cost to participate: $0 — study care and visits are covered by the sponsor
- Worth knowing: Fewer trials run here than in neighboring states — remote and decentralized studies are a practical option for Nevadans
What’s being studied in Nevada right now
We sampled recruiting Nevada studies on ClinicalTrials.gov in July 2026. The most active sites and most-studied conditions:
| Most active research sites | Most-studied conditions |
|---|---|
| Renown Regional Medical Center, Reno (82 site listings) | Obesity and overweight |
| Comprehensive Cancer Centers of Nevada, Las Vegas (58) | Major depressive disorder |
| OptumCare Cancer Care, Las Vegas (99 across two sites) | Acute myeloid leukemia |
| Cure 4 the Kids Foundation, Las Vegas (50) | Crohn’s disease |
Nevada’s trial mix is unusual: obesity and depression studies rank ahead of most cancer types, and Cure 4 the Kids gives Las Vegas a dedicated pediatric research site. If you don’t see a match locally, remote studies and the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas are worth checking.
Clinical Trials For Disease Areas in Nevada
Clinical research trials in Nevada encompass a diverse array of disease areas. These studies play a key role in improving treatment options, patient outcomes, and expanding medical knowledge.
Some of the state’s notable research strengths are in the fields of cancer research, cardiovascular health, neurological disorders, diabetes management, pediatric health, and gastrointestinal disorders.
For example, the Center for Molecular and Cellular Signal Transduction in the Cardiovascular System is Nevada’s first center that focuses on the basics of cardiovascular science. It became available thanks to the $11 million grant advances by the NIH.
Here is a list of upcoming and ongoing trials in the Nevada area.
Mucopolysaccharidosis I (MPS I) Registry
Recruiting
The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients receiving enzyme replacement therapy, such as Aldurazyme (Recombinant Human Alpha-L-Iduronidase), or other treatment modalities.
The objectives of the Registry are:
* To evaluate the lon... Read More
The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients receiving enzyme replacement therapy, such as Aldurazyme (Recombinant Human Alpha-L-Iduronidase), or other treatment modalities.
The objectives of the Registry are:
* To evaluate the long-term effectiveness and safety of Aldurazyme® (laronidase)
* To characterize and describe the MPS I population as a whole, including the variability, progression, and natural history of MPS I
* To help the MPS I medical community with the development of recommendations for monitoring patients and reports on patient outcomes to optimize patient care Read Less
Gender:
ALL
Ages:
All
Trial Updated:
11/19/2024
Locations: Children's Specialty Center of Nevada- Site Number : 840008, Las Vegas, Nevada
Children's Specialty Center of Nevada- Site Number : 840008, Las Vegas, Nevada
Conditions: Mucopolysaccharidosis I (MPS I)
Fabry Disease Registry & Pregnancy Sub-registry
Recruiting
The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician.
The primary objectives of the Registry are:
* To enhance the understanding of the variability, progression, and natural history of F... Read More
The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician.
The primary objectives of the Registry are:
* To enhance the understanding of the variability, progression, and natural history of Fabry disease, including heterozygous females with the disease;
* To assist the Fabry medical community with the development of recommendations for monitoring patients and reports on patient outcomes to help optimize patient care;
* To characterize and describe the Fabry population as a whole;
* To evaluate the long-term safety and effectiveness of Fabrazyme®
Fabry Pregnancy Sub-registry: This Sub-registry is a multicenter, international, longitudinal, observational, and voluntary program designed to track pregnancy outcomes for any pregnant woman enrolled in the Fabry Registry, regardless of whether she is receiving disease-specific therapy (such as enzyme replacement therapy with agalsidase beta) and irrespective of the commercial product with which she may be treated. Data from the Sub-registry are also used to fulfill various global regulatory requirements, to support product development/reimbursement, and for other research and non-research-related purposes. No experimental intervention is given; thus a patient will undergo clinical assessments and receive standard of care treatment as determined by the patient's physician. If a patient consents to this Sub-registry, information about the patient's medical and obstetric history, pregnancy, and birth will be collected, and, if a patient consents to data collection for her infant, data on infant growth through month 36 postpartum will be collected. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
08/07/2025
Locations: Children's Specialty Center of Nevada- Site Number : 840008, Las Vegas, Nevada
Children's Specialty Center of Nevada- Site Number : 840008, Las Vegas, Nevada
Conditions: Fabry Disease
Pompe Disease Registry Protocol
Recruiting
The Pompe Registry is a global, multicenter, international, longitudinal, observational, and voluntary program for patients with Pompe disease, designed to track the disease's natural history and outcomes in patients, both treated and not. Data from the Registry are also used to fulfill various global regulatory commitments, to support product development/reimbursement, and for other research and non-research related purposes.
The objectives of the Registry are:
* To enhance understanding of t... Read More
The Pompe Registry is a global, multicenter, international, longitudinal, observational, and voluntary program for patients with Pompe disease, designed to track the disease's natural history and outcomes in patients, both treated and not. Data from the Registry are also used to fulfill various global regulatory commitments, to support product development/reimbursement, and for other research and non-research related purposes.
The objectives of the Registry are:
* To enhance understanding of the variability, progression, identification, and natural history of Pompe disease, with the ultimate goal of better guiding and assessing therapeutic intervention.
* To assist the Pompe medical community with the development of recommendations for monitoring patients, and to provide reports on patient outcomes, to optimize patient care.
* To characterize the Pompe disease population.
* To evaluate the long-term effectiveness of alglucosidase alfa. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
08/06/2025
Locations: Children's Specialty Center of Nevada- Site Number : 840008, Las Vegas, Nevada
Children's Specialty Center of Nevada- Site Number : 840008, Las Vegas, Nevada
Conditions: Glycogen Storage Disease Type II, Pompe Disease
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Recruiting
The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician.
The objectives of the Registry are:
* To enhance understanding of the variability, progression, identification, and natural... Read More
The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician.
The objectives of the Registry are:
* To enhance understanding of the variability, progression, identification, and natural history of Gaucher disease, with the ultimate goal of better guiding and assessing therapeutic intervention.
* To assist the Gaucher medical community with the development of recommendations for monitoring patients, and to provide reports on patient outcomes, to optimize patient care.
* To characterize the Gaucher disease population.
* To evaluate the long-term effectiveness of imiglucerase and of eliglustat.
Gaucher Pregnancy Sub-registry: The primary objective of this Sub-registry is to track pregnancy outcomes, including complications and infant growth, in all women with Gaucher disease during pregnancy, regardless of whether they receive disease-specific therapy. No experimental intervention is given; thus a patient will undergo clinical assessments and receive standard of care treatment as determined by the patient's physician.If a patient consents to this Sub-registry, information about the patient's medical and obstetric history, pregnancy, and birth will be collected, and, if a patient consents to data collection for her infant, data on infant growth through month 36 postpartum will be collected. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
08/12/2025
Locations: Children's Specialty Center of Nevada- Site Number : 840008, Las Vegas, Nevada
Children's Specialty Center of Nevada- Site Number : 840008, Las Vegas, Nevada
Conditions: Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Recruiting
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
07/22/2025
Locations: University Medical Center of Southern Nevada, Las Vegas, Nevada +3 locations
University Medical Center of Southern Nevada, Las Vegas, Nevada
Sunrise Hospital and Medical Center, Las Vegas, Nevada
Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada
Summerlin Hospital Medical Center, Las Vegas, Nevada
Conditions: Hematopoietic Cell Transplantation Recipient, Leukemia, Solid Tumor
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Recruiting
This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. Read Less
Gender:
ALL
Ages:
30 years and below
Trial Updated:
04/14/2025
Locations: University Medical Center of Southern Nevada, Las Vegas, Nevada +3 locations
University Medical Center of Southern Nevada, Las Vegas, Nevada
Sunrise Hospital and Medical Center, Las Vegas, Nevada
Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada
Summerlin Hospital Medical Center, Las Vegas, Nevada
Conditions: Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
Recruiting
This study is a registry of general use of Avance Nerve Graft and is intended to evaluate the uses, response rates, and safety of Avance Nerve Graft in the real-life clinical setting. Optional addendums 1 and 2 included in the protocol are intended to establish comparative groups and focused subgroups within the registry.
This study is a registry of general use of Avance Nerve Graft and is intended to evaluate the uses, response rates, and safety of Avance Nerve Graft in the real-life clinical setting. Optional addendums 1 and 2 included in the protocol are intended to establish comparative groups and focused subgroups within the registry. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
07/25/2025
Locations: Sensation-NOW: University of Nevada, Las Vegas, Las Vegas, Nevada
Sensation-NOW: University of Nevada, Las Vegas, Las Vegas, Nevada
Conditions: Peripheral Nerve Injuries
A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
Recruiting
The purpose of this study is to evaluate performance of the Vanguard 360 revision knee system utilizing offset on either the tibial component, femoral component, or both in terms of the restoration of mechanical alignment, clinical outcomes and survivorship.
The purpose of this study is to evaluate performance of the Vanguard 360 revision knee system utilizing offset on either the tibial component, femoral component, or both in terms of the restoration of mechanical alignment, clinical outcomes and survivorship. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/20/2025
Locations: Orthopedic Institute of Henderson, Henderson, Nevada
Orthopedic Institute of Henderson, Henderson, Nevada
Conditions: Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis, Post Traumatic Deformity, Complications; Arthroplasty, Deformity of Limb
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Recruiting
Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into the study. With annual assessments and no end date, Enroll-HD has built a large and rich database of longitudinal clinical data and biospecimens that form the basis for studies developing tools and b... Read More
Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into the study. With annual assessments and no end date, Enroll-HD has built a large and rich database of longitudinal clinical data and biospecimens that form the basis for studies developing tools and biomarkers for progression and prognosis, identifying clinically-relevant phenotypic characteristics, and establishing clearly defined endpoints for interventional studies. Periodic cuts of the database are now available to any interested researcher to use in their research - visit www.enroll-hd.org/for-researchers/access-data/ to learn more. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/26/2024
Locations: Cleveland Clinic - Las Vegas, Las Vegas, Nevada
Cleveland Clinic - Las Vegas, Las Vegas, Nevada
Conditions: Huntington's Disease
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
Recruiting
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Directions for Use
- and -
To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Directions for Use
- and -
To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/11/2025
Locations: Hope Research Institute, Las Vegas, Nevada
Hope Research Institute, Las Vegas, Nevada
Conditions: Pain
Paid Clinical Trials in Nevada
Paid clinical trials in Nevada are quite popular among the general population. As a way to thank volunteers for participating, people can earn a couple of hundred dollars per day for every clinical trial they participate in.
Nevada paid clinical trials also offer reimbursement for other expenses. Such as gas, accommodation, etc. Payment varies based on the length of the trial, the trial phase, the number of overnight stays, and other risks that come with it.
Clinical Trials For Health Volunteers in Nevada
For medical research to move forward, health volunteers have a chance to be a part of something big. They can help research teams in Nevada collect valuable data and assess different health conditions, medications, and health outcomes.
Want to make a difference in healthcare? Here is a list of some of the latest clinical trials near you.
A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways
Recruiting
In this study, researchers will learn how the body processes litifilimab when it is given under the skin in 3 different ways. Currently, ongoing studies utilize pre-filled syringes (PFS) that can deliver litifilimab subcutaneously (SC), also known as under the skin.
In this study, researchers want to learn more about new ways of delivering litifilimab SC using either an autoinjector (AI) or an on-body injector (OBI):
Both devices are designed to deliver litifilimab in an automatic way, especia... Read More
In this study, researchers will learn how the body processes litifilimab when it is given under the skin in 3 different ways. Currently, ongoing studies utilize pre-filled syringes (PFS) that can deliver litifilimab subcutaneously (SC), also known as under the skin.
In this study, researchers want to learn more about new ways of delivering litifilimab SC using either an autoinjector (AI) or an on-body injector (OBI):
Both devices are designed to deliver litifilimab in an automatic way, especially helping patients who may not be able to use their hands very well, or who may be afraid of needles. While the AI is handheld, the OBI device works by being placed on the skin and can help deliver the highest amount of litifilimab through a single injection. The main objective of this study is to learn how the body processes litifilimab after using the AI device or the OBI device, as compared to using the PFS method.
The main questions researchers want to answer are:
* What is the highest amount of litifilimab found in the blood after dosing? How much total litifilimab is found in the blood throughout the study? Researchers will also learn more about: Any medical problems the participants have during the study
* Any injection site pain or reactions the participants may have. Any skin reactions to the OBI device
* Any changes in the participants' overall health after receiving litifilimab.
This study will be done as follows:
* Participants will be screened to check if they can join the study. The screening period will be up to 4 weeks, after which selected participants will check into their study research center.
* Participants will be randomly assigned to be in Part 1 or Part 2 of the study:
* Part 1: Participants will receive SC injection(s) of litifilimab through either the AI device or through PFS.
* Part 2: Participants will receive SC injection(s) of litifilimab through the OBI device or through PFS.
* Participants will remain at their study research center for the first 8 days. After that, there will be a follow-up period for 17 weeks during which participants return to the center a total of 6 times.
Each participant will be in the study for about 22 weeks. Read Less
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
08/19/2025
Locations: Las Vegas Clinical Research Unit, Las Vegas, Nevada
Las Vegas Clinical Research Unit, Las Vegas, Nevada
Conditions: Healthy Volunteer
A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult Participants
Recruiting
This study will assess the pharmacokinetics and relative Bioavailability of risankizumab following subcutaneous administration with an on-body injector relative to a prefilled syringe
This study will assess the pharmacokinetics and relative Bioavailability of risankizumab following subcutaneous administration with an on-body injector relative to a prefilled syringe Read Less
Gender:
ALL
Ages:
Between 18 years and 60 years
Trial Updated:
06/16/2025
Locations: Ppd - Las Vegas Research Unit /ID# 276565, Las Vegas, Nevada
Ppd - Las Vegas Research Unit /ID# 276565, Las Vegas, Nevada
Conditions: Healthy Volunteers
Medical Discoveries and Innovation in Nevada
Nevada research teams have contributed real advances despite the state’s smaller footprint. NV experts often collaborate with medical practitioners from around the country and the world. Here are some of the most impactful innovations made in the area:
- Advancements in neurology: Neurology specialists from the University of Nevada are active contributors to a number of therapy developments. That includes acute stroke therapy, stroke prevention therapy, and Botox® for preventing migraines.
- Cancer treatment innovations: Prof. Bahram Parvin, a Nevada specialist, received $2.2 million to develop a new cancer therapeutic. This therapeutic can reprogram the tumor microenvironment. This innovation could improve patient outcomes in battling various forms of cancer.
- Pioneering diabetes research: A researcher from the University of Nevada, discovered a link at a molecular level between type 2 diabetes and obesity. This finding could pave the way for new medications that specifically target these conditions.
Nevada Paid Clinical Trial FAQs
-
How much do paid clinical trials pay in Nevada?
Most outpatient studies in Nevada pay $50–$100 per completed visit, plus travel reimbursement. The exact amount appears in the consent form before you enroll.
-
Why are there fewer trials in Nevada than nearby states?
Nevada has no large academic medical center on the scale of a UCLA or Mayo, so most trials run through hospital systems and private research sites in Las Vegas and Reno. That means fewer options, but also less competition for spots in the studies that do run here.
-
Can I join a trial without leaving Nevada?
Usually, yes. Las Vegas and Reno cover most specialties between them, and a growing share of studies run remotely with home visits or telehealth check-ins. For rare conditions, coordinators can often refer you to the nearest out-of-state site and some sponsors cover travel.
Why Nevada Is A Great Place For Clinical Research
Diversifying trials can be highly beneficial for collecting more accurate data. According to reports, the Nevada population is diverse. Exactly 46.6% of its residents are white, 29.9% are Hispanic, 9.6% are black, 8.6% are Asian, 3.8% are multiracial, 0.8% are American Indian, and 0.7% are Native Hawaiian.